BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36546536)

  • 1. Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection.
    Yang W; Shou C; Chen Z; Hong Y; Yu H; Wang X; Wu Z; Zhang Q; Gao Y; Yu J
    Scand J Gastroenterol; 2023 Jun; 58(6):684-692. PubMed ID: 36546536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
    Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
    Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
    Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
    Front Oncol; 2020; 10():581855. PubMed ID: 33585198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
    Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
    World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of Prognostic Nutritional Index (PNI) for 5-year recurrence-free survival in surgically resected gastrointestinal stromal tumors.
    Duymus ME; Ugur M; Dal MB; Aslan ER; Donmez Y; Ozgur T; Secinti IE; Bag YM; Temiz M
    Ann Ital Chir; 2023; 94():19-26. PubMed ID: 36810307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
    Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
    EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
    Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
    Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen/Albumin Ratio Index Is an Independent Prognosis Predictor of Recurrence-Free Survival in Patients After Surgical Resection of Gastrointestinal Stromal Tumors.
    Cao X; Cui J; Yu T; Li Z; Zhao G
    Front Oncol; 2020; 10():1459. PubMed ID: 33014783
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
    Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
    Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients.
    Chok AY; Goh BK; Koh YX; Lye WK; Allen JC; Quek R; Teo MC; Chow PK; Ong HS; Chung AY; Wong WK
    Ann Surg Oncol; 2015 Oct; 22(11):3597-605. PubMed ID: 25652053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
    Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
    Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of prognostic nutritional index with prognosis of gastrointestinal stromal tumors.
    Sun J; Mei Y; Zhu Q; Shou C; Tjhoi WEH; Yang W; Yu H; Zhang Q; Liu X; Yu J
    J Cancer; 2019; 10(12):2679-2686. PubMed ID: 31258776
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive ability of prognostic nutritional index in surgically resected gastrointestinal stromal tumors: a propensity score matching analysis.
    Shi WK; Zhang XH; Zhang J; Yu M; Yuan YJ; Xiong W; Zhang CH; He YL; Wei ZW
    Jpn J Clin Oncol; 2019 Sep; 49(9):823-831. PubMed ID: 31162583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of modified NIH and AFIP risk-stratification criteria for gastrointestinal stromal tumors: A multicenter retrospective study].
    Chen T; Qiou H; Feng X; Zhang P; Ye L; Hu Y; Liu H; Yu J; Tao K; Li Y; Zhou Z; Li G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1020-1024. PubMed ID: 28900993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
    Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.
    Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP
    Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
    Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
    Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological significance of the Prognostic Nutritional Index in patients with gastrointestinal stromal tumours undergoing surgery: a meta-analysis.
    Kang N; Gu H; Ni Y; Wei X; Zheng S
    BMJ Open; 2022 Dec; 12(12):e064577. PubMed ID: 36456008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of Onodera's nutritional index for intermediate- and high-risk gastrointestinal stromal tumors treated with or without tyrosine kinase inhibitors.
    Wang F; Tao T; Yu H; Xu Y; Yang Z; Xia X; Wang M; Zong L; Guan W
    World J Surg Oncol; 2021 Aug; 19(1):227. PubMed ID: 34344373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.